Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Implementation of a multidisciplinary treatment team for hepatocellular cancer at a Veterans Affairs Medical Center improves survival.

Chang TT, Sawhney R, Monto A, Davoren JB, Kirkland JG, Stewart L, Corvera CU.

HPB (Oxford). 2008;10(6):405-11. doi: 10.1080/13651820802356572.

2.

The effect of a regional hepatopancreaticobiliary surgical program on clinical volume, quality of cancer care, and outcomes in the Veterans Affairs system.

Lau K, Salami A, Barden G, Khawja S, Castillo DL, Poppelaars V, Artinyan A, Awad SS, Berger DH, Albo D, Anaya DA.

JAMA Surg. 2014 Nov;149(11):1153-61. doi: 10.1001/jamasurg.2014.1711.

PMID:
25207711
3.

Statin-Based Palliative Therapy for Hepatocellular Carcinoma.

Shao JY, Lee FP, Chang CL, Wu SY.

Medicine (Baltimore). 2015 Oct;94(42):e1801. doi: 10.1097/MD.0000000000001801.

4.

Establishment of a multidisciplinary hepatocellular carcinoma clinic is associated with improved clinical outcome.

Yopp AC, Mansour JC, Beg MS, Arenas J, Trimmer C, Reddick M, Pedrosa I, Khatri G, Yakoo T, Meyer JJ, Shaw J, Marrero JA, Singal AG.

Ann Surg Oncol. 2014 Apr;21(4):1287-95. doi: 10.1245/s10434-013-3413-8. Epub 2013 Dec 7.

PMID:
24318095
5.

Multidisciplinary care of hepatocellular carcinoma.

Van Cleave J, Devine P, Odom-Ball P.

Cancer Pract. 1999 Nov-Dec;7(6):302-8.

PMID:
10732528
6.

Imaging surveillance and multidisciplinary review improves curative therapy access and survival in HCC patients.

Gaba RC, Kallwitz ER, Parvinian A, Bui JT, Von Roenn NM, Berkes JL, Cotler SJ.

Ann Hepatol. 2013 Sep-Oct;12(5):766-73.

7.

Multimodality treatment for patients with hepatocellular carcinoma: analysis of prognostic factors in a single Western institution series.

Medina-Franco H, Sellers MT, Eckhoff DE, Bynon JS, Urist MM, Heslin MJ.

J Gastrointest Surg. 2001 Nov-Dec;5(6):638-45.

PMID:
12086903
8.

Cyproheptadine use in hepatocellular carcinoma.

Hsieh MC, Lee WH, Wu AT, Chow JM, Chang CL, Yuan KS, Wu SY.

Am J Cancer Res. 2017 Mar 1;7(3):584-602. eCollection 2017.

9.

A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma.

Zhong C, Guo RP, Li JQ, Shi M, Wei W, Chen MS, Zhang YQ.

J Cancer Res Clin Oncol. 2009 Oct;135(10):1437-45. doi: 10.1007/s00432-009-0588-2. Epub 2009 May 1.

PMID:
19408012
10.

Treatment of hepatocellular carcinoma.

Tang ZY.

Digestion. 1998 Aug;59(5):556-62. Review.

PMID:
9705539
11.

Laparoscopic liver resection: 5-year experience at a single center.

Long TC, Bac NH, Thuan ND, Dat le T, Viet DQ, Chuong le CH.

Surg Endosc. 2014 Mar;28(3):796-802. doi: 10.1007/s00464-013-3259-y. Epub 2013 Nov 7.

12.

Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.

Choi HJ, Kim DG, Na GH, Han JH, Hong TH, You YK.

World J Gastroenterol. 2013 Aug 7;19(29):4737-44. doi: 10.3748/wjg.v19.i29.4737.

13.

The effect of a lung cancer care coordination program on timeliness of care.

Alsamarai S, Yao X, Cain HC, Chang BW, Chao HH, Connery DM, Deng Y, Garla VN, Hunnibell LS, Kim AW, Obando JA, Taylor C, Tellides G, Rose MG.

Clin Lung Cancer. 2013 Sep;14(5):527-34. doi: 10.1016/j.cllc.2013.04.004. Epub 2013 Jul 1.

PMID:
23827516
14.

Multimodal therapy for hepatocellular carcinoma: a complementary approach to liver transplantation.

Schumacher PA, Powell JJ, MacNeill AJ, Buczkowski AK, Erb SR, Ho SG, Scudamore CH, Steinbrecher UP, Weiss A, Yoshida E, Chung SW.

Ann Hepatol. 2010 Jan-Mar;9(1):23-32.

PMID:
20308719
15.

Effect of Liver Transplant on Long-term Disease-Free Survival in Children With Hepatoblastoma and Hepatocellular Cancer.

Pham TA, Gallo AM, Concepcion W, Esquivel CO, Bonham CA.

JAMA Surg. 2015 Dec;150(12):1150-8. doi: 10.1001/jamasurg.2015.1847.

PMID:
26308249
16.

Prognostic value and clinical relevance of the 6th Edition 2002 American Joint Committee on Cancer staging system in patients with resectable hepatocellular carcinoma.

Lei HJ, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Wu CW.

J Am Coll Surg. 2006 Oct;203(4):426-35. Epub 2006 Aug 23.

PMID:
17000385
17.

Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.

Yamamoto Y, Ikoma H, Morimura R, Shoda K, Konishi H, Murayama Y, Komatsu S, Shiozaki A, Kuriu Y, Kubota T, Nakanishi M, Ichikawa D, Fujiwara H, Okamoto K, Sakakura C, Ochiai T, Otsuji E.

World J Gastroenterol. 2015 Jan 7;21(1):246-53. doi: 10.3748/wjg.v21.i1.246.

18.

Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage, treatment received, and survival.

Leykum LK, El-Serag HB, Cornell J, Papadopoulos KP.

Clin Gastroenterol Hepatol. 2007 Apr;5(4):508-12. Epub 2007 Mar 26.

PMID:
17382601
19.

Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.

Davila JA, Henderson L, Kramer JR, Kanwal F, Richardson PA, Duan Z, El-Serag HB.

Ann Intern Med. 2011 Jan 18;154(2):85-93. doi: 10.7326/0003-4819-154-2-201101180-00006.

PMID:
21242365
20.

Supplemental Content

Support Center